---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-114224"
form_type: "8-K"
ticker: "REPL"
cik: "0001737953"
company_name: "Replimune Group, Inc."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T09:32:59.068865+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Replimune Q2 net loss $43.1M; CERPASS enrollment complete, cash runway extended into 2025

## Summary
- Net loss of $43.1M for Q2 FY2022 (vs $29.4M in Q2 FY2021); R&D expenses $28.8M.
- Completed enrollment in CERPASS trial (n=211) of RP1+Libtayo in CSCC; primary data expected H1 2023.
- Six-month data from first 75 patients in IGNYTE (RP1+Opdivo anti-PD1 failed melanoma) expected by year-end.
- Closed $200M term loan with Hercules Capital; cash and investments $371.8M as of Sep 30, 2022.
- Cash runway extended into 2025, covering commercial infrastructure and confirmatory trial costs.

## SEC filing metadata
- accession: 0001104659-22-114224
- form_type: 8-K
- ticker: REPL
- cik: 0001737953
- company_name: Replimune Group, Inc.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737953/000110465922114224/0001104659-22-114224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737953/000110465922114224/tm2229523d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-114224
- JSON: https://secwatch.observer/filing/0001104659-22-114224.json
- Plain text: https://secwatch.observer/filing/0001104659-22-114224.txt

## Key facts
- Earnings Releases
  Replimune Group, Inc. reported financial results for second quarter ended September 30, 2022.
  - Period: second quarter ended September 30, 2022
  - Result: reported results
  source text: On November 3, 2022, Replimune Group, Inc. issued a news release announcing its financial results for the second quarter ended September 30, 2022 and certain corporate updates.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737953/000110465922114224/0001104659-22-114224-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.